Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT03254823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2025-03-30
Summary
This study investigates whether there is an immune response directed against gut microbes or food and parts of the body in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients.
Conditions
- Myalgic Encephalomyelitis
- Chronic Fatigue Syndrome
Sponsors & Collaborators
-
Quadram Institute Bioscience
collaborator OTHER -
Invest in ME Research UK
collaborator UNKNOWN -
University of East Anglia
lead OTHER
Principal Investigators
-
Simon Carding · Quadram Institute Bioscience
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-09
- Primary Completion
- 2022-08-30
- Completion
- 2022-08-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE
NCT01702038 ·Status: WITHDRAWN ·Phase: PHASE2
-
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
NCT06946485 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Fatigue in Systemic Lupus Erythematosus
NCT06652256 ·Status: COMPLETED
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
NCT05022420 ·Status: RECRUITING
-
Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy
NCT05689463 ·Status: RECRUITING ·Phase: NA
-
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
NCT01156909 ·Status: COMPLETED ·Phase: PHASE2
-
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156 ·Status: COMPLETED ·Phase: NA
-
T and B Cell Responses in Autoimmune Diseases
NCT01947036 ·Status: TERMINATED
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
NCT00042523 ·Status: COMPLETED
-
FolateScan in Autoimmune Disease
NCT00588393 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Patients With Autoimmune Disease
NCT05842824 ·Status: NOT_YET_RECRUITING
-
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
NCT04726553 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
NCT01261793 ·Status: COMPLETED ·Phase: PHASE3
-
Catalytic Antibodies and Lupus in Martinique
NCT01157468 ·Status: COMPLETED
-
Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases
NCT04690816 ·Status: COMPLETED
-
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
NCT02925351 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Occupational and Environmental Causes of Autoimmune Diseases
NCT07000903 ·Status: COMPLETED ·Phase: NA
-
Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 ·Status: UNKNOWN
-
Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415 ·Status: RECRUITING
-
Comparative Autoantibody and Immunologic Cell Marker Study
NCT02422875 ·Status: ENROLLING_BY_INVITATION
-
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560 ·Status: COMPLETED